NZM2:ETR
Novozymes A/S
€62.68
arrow_upward
+0.48%(+0.30) 1D
Oct 30, 5:30:00 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NZM2...
Open
€62.70
High
€62.70
Low
€62.68
Mkt. cap
191.52B
Avg. vol.
123.00
Volume
0.00
52-wk high
€63.82
52-wk low
€46.74
No. of employees
11K
Open
€62.70
High
€62.70
Low
€62.68
Mkt. cap
191.52B
Avg. vol.
123.00
Volume
0.00
52-wk high
€63.82
52-wk low
€46.74
No. of employees
11K
News stories
From web sources and news partners
24/7 Wall St.
·
7 hours ago
S&P Says Meta Can’t Make Money From AI as Well as Its Rivals
TradingView
·
9 hours ago
Nifty 500 vs S&P 500: India or US, innovation is the only game in town for investors
www.tokenpost.com
·
4 hours ago
Tech sell-off opens scope for a short-term rebound as oil tests S&P 500 uptrend
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, Greater Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S